Form 4: Quest Diagnostics Director Acquires Shares Through Dividend Reinvestment

Director Vicky B. Gregg acquired 72 shares of Quest Diagnostics stock through dividend reinvestment on January 29, 2025.

Summary

• Vicky B. Gregg, a director at Quest Diagnostics, acquired 72 shares of common stock on January 29, 2025.
• The shares were acquired through dividend reinvestment at a price of $158.037 per share.
• Following the transaction, Ms. Gregg directly owns 18,117 shares of Quest Diagnostics stock.
• This transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as it reflects a routine transaction of a director acquiring shares through dividend reinvestment, indicating confidence in the company.

Positives

• The acquisition of shares by a director through dividend reinvestment can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine transaction for a director of a public company and is not indicative of any specific industry trend.

Comparison to Industry Standards

• Director share acquisitions through dividend reinvestment are common among publicly traded companies.
• This transaction is similar to other insider transactions reported by directors of comparable companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows a director's continued investment in the company.

Key Dates

Keywords

Quest Diagnostics, Director, Vicky B. Gregg, Dividend Reinvestment, Share Acquisition, Form 4, SEC Filing, DGX